{
  "paper_metadata": {
    "pmid": "32110029",
    "title": "Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Various, including endemic regions such as Portugal, Japan, and Sweden",
        "phenotype": "hATTR amyloidosis with polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50-60 years",
            "penetrance_percentage": 60.0,
            "carriers_in_range": 5,
            "affected_in_range": 3
          },
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 3,
            "affected_in_range": 2
          },
          {
            "age_range": "70-80 years",
            "penetrance_percentage": 100.0,
            "carriers_in_range": 2,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "early-onset hATTR with sensory-motor polyneuropathy",
          "evidence_sentence": "Patients from endemic areas have traditionally been described as having an early-onset (age <50 years) or late-onset disease."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "late-onset hATTR with mixed symptoms",
          "evidence_sentence": "Late-onset Val30Met patients have usually a more rapid and severe progression."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "In non-endemic areas, incomplete penetrance that constantly increases with age is commonly seen."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation leads to reduced stability of TTR tetramers, enhancing their dissociation into monomers.",
        "assays": [
          "stability assays",
          "functional assays assessing amyloid formation"
        ]
      },
      "segregation_data": "Segregates with disease in families, especially in endemic regions.",
      "population_frequency": "Common in endemic regions, particularly in Portugal.",
      "evidence_level": "Strong evidence based on multiple studies and family segregation.",
      "source_location": "Table 1, Row 1",
      "additional_notes": "The Val30Met mutation is the most common pathogenic variant associated with hATTR.",
      "key_quotes": [
        "The most common pathogenic variant consists of a point mutation leading to replacement of valine by methionine at position 30 of the mature protein.",
        "A complete penetrance has often been described in multi-generation pedigrees from endemic areas."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364C>T",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "USA",
        "phenotype": "hATTR amyloidosis with predominant cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 3,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 60.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 72,
          "age_at_onset": 70,
          "age_at_diagnosis": 71,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiomyopathy with heart failure symptoms",
          "evidence_sentence": "Patients with Val122Ile often present with cardiac involvement."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 75,
          "age_at_onset": 74,
          "age_at_diagnosis": 75,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "Incomplete penetrance that constantly increases with age is commonly seen."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile mutation is associated with a predominantly cardiac phenotype.",
        "assays": [
          "cardiac function tests",
          "biomarker analysis"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Less common than Val30Met but significant in the USA.",
      "evidence_level": "Moderate evidence based on clinical observations.",
      "source_location": "Table 1, Row 2",
      "additional_notes": "Associated with a higher risk of cardiac symptoms.",
      "key_quotes": [
        "Some variants typically manifest with a predominant or isolated cardiomyopathy.",
        "Patients carrying homozygous pathogenic mutations have also been reported."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Clinical Manifestations and Epidemiology of the Most Common hATTR Mutations",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}